cbdMD, Inc.
YCBD • AMEX
cbdMD, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on AMEX, led by CEO T. Ronan Kennedy, with a market cap of $7.6M.
CEOT. Ronan Kennedy
Next Earnings
Upcoming earnings announcement for cbdMD, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.05
Revenue Estimate
$5.3M
Earnings History
Past 12 earnings reports for cbdMD, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q1 2026 | -$0.04Est: -$0.06 | +33.3% | $5.0MEst: $4.9M | +3.3% |  10-Q |
| Dec 19, 2025 | Q4 2025 | -$0.08Est: -$0.07 | -14.3% | $4.7MEst: $4.7M | +0.4% | 10-K/A |
| Aug 14, 2025 | Q3 2025 | -$0.21 | — | $4.6MEst: $5.3M | -13.1% | 10-Q |
| May 15, 2025 | Q2 2025 | -$1.90Est: $0.00 | — | $4.8MEst: $5.1M | -6.6% | 10-Q |
| Feb 13, 2025 | Q1 2025 | -$0.22 | — | $5.1M | — | 10-Q |
| Dec 18, 2024 | Q4 2024 | -$0.18Est: $0.00 | — | $4.6MEst: $4.8M | -5.3% | 10-K/A |
| Aug 14, 2024 | Q3 2024 | -$0.15Est: -$0.62 | +75.8% | $5.2MEst: $4.9M | +4.9% | 10-Q |
| May 15, 2024 | Q2 2024 | -$1.35Est: -$0.75 | -80.0% | $4.4MEst: $5.4M | -18.9% | 10-Q |
| Feb 13, 2024 | Q1 2024 | -$0.67Est: -$0.74 | +9.5% | $5.4MEst: $5.8M | -7.3% | — |
| Dec 22, 2023 | Q4 2023 | -$9.06 | — | $5.7M | — | — |
| Aug 10, 2023 | Q3 2023 | -$1.16 | — | $6.1M | — | — |
| May 15, 2023 | Q2 2023 | -$1.74 | — | $6.2M | — | — |